crispr/cas9 ccr5 gene modified cd34+ hematopoietic stem cells
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 30, 2017 (NCT03164135)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- crispr/cas9 ccr5 gene modified cd34+ hematopoietic stem cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03164135 | N/A | May 30, 2017 | Capital Medical University, Peking University, People's Liberation Army of China |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2017 |
3 organizations
Page 1 / 1